Nishan M Desilva - Net Worth and Insider Trading
Nishan M Desilva Net Worth
The estimated net worth of Nishan M Desilva is at least $2 Million dollars as of 2024-06-05. Nishan M Desilva is the VP, Finance & Strategy and CFO of Ligand Pharmaceuticals Inc and owns about 22,282 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. Nishan M Desilva is also the Director of Cartesian Therapeutics Inc and owns about 233 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $8,608. Details can be seen in Nishan M Desilva's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nishan M Desilva has not made any transactions after 2021-12-02 and currently still holds the listed stock(s).
Transaction Summary of Nishan M Desilva
Nishan M Desilva Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nishan M Desilva owns 2 companies in total, including Ligand Pharmaceuticals Inc (LGND) , and Cartesian Therapeutics Inc (RNAC) .
Click here to see the complete history of Nishan M Desilva’s form 4 insider trades.
Insider Ownership Summary of Nishan M Desilva
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LGND | Ligand Pharmaceuticals Inc | 2015-05-14 | VP & Corporate Development |
RNAC | Cartesian Therapeutics Inc | 2021-12-02 | director |
Nishan M Desilva Latest Holdings Summary
Nishan M Desilva currently owns a total of 2 stocks. Among these stocks, Nishan M Desilva owns 22,282 shares of Ligand Pharmaceuticals Inc (LGND) as of May 14, 2015, with a value of $2 Million and a weighting of 99.54%. Nishan M Desilva also owns 233 shares of Cartesian Therapeutics Inc (RNAC) as of December 2, 2021, with a value of $8,608 and a weighting of 0.46%.
Latest Holdings of Nishan M Desilva
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LGND | Ligand Pharmaceuticals Inc | 2015-05-14 | 22,282 | 82.92 | 1,847,623 |
RNAC | Cartesian Therapeutics Inc | 2021-12-02 | 233 | 36.95 | 8,608 |
Holding Weightings of Nishan M Desilva
Nishan M Desilva Form 4 Trading Tracker
According to the SEC Form 4 filings, Nishan M Desilva has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 68,363 shares on May 14, 2015, which brought Nishan M Desilva around $6 Million.
According to the SEC Form 4 filings, Nishan M Desilva has made a total of 1 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 233 shares on December 2, 2021, which cost Nishan M Desilva around $20,720.
Insider Trading History of Nishan M Desilva
- 1
Nishan M Desilva Trading Performance
GuruFocus tracks the stock performance after each of Nishan M Desilva's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nishan M Desilva is -13.35%. GuruFocus also compares Nishan M Desilva's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nishan M Desilva within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nishan M Desilva's insider trading performs compared to the benchmark.
Performance of Nishan M Desilva
Nishan M Desilva Ownership Network
Ownership Network List of Nishan M Desilva
Ownership Network Relation of Nishan M Desilva
Nishan M Desilva Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Nishan M Desilva is the VP & Corporate Development of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , VP & Finance and CFO Matthew E Korenberg , and CHIEF LEGAL OFFICER & Andrew Reardon .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Nishan M Desilva made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 13,433 shares made by Octavio Espinoza , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 10,300 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 41,825 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 41,825 shares. During the past 18 months, 71,418 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 67,418 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Nishan M Desilva Mailing Address
Above is the net worth, insider trading, and ownership report for Nishan M Desilva. You might contact Nishan M Desilva via mailing address: 11119 North Torrey Pines Rd Ste 200, La Jolla Ca 92037.